Logo image
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study
Journal article   Open access   Peer reviewed

Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study

Casey M. Rebholz, Brad C. Astor, Morgan E. Grams, Marc K. Halushka, Mariana Lazo, Ron C. Hoogeveen, Christie M. Ballantyne, Josef Coresh and Elizabeth Selvin
Nephrology, dialysis, transplantation, v 30(1), pp 77-83
01 Jan 2015
PMID: 25147225
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1093/ndt/gfu282View
Published, Version of Record (VoR) Open

Abstract

Life Sciences & Biomedicine Science & Technology Transplantation Urology & Nephrology
Background. Advanced glycation end products and their cell-bound receptors are thought to mediate the adverse effects of vascular disease through oxidative stress, inflammation and endothelial dysfunction. We examined the association between the soluble form of receptor for advanced glycation end products (sRAGE) and kidney disease. Methods. In this case-cohort study nested within the Atherosclerosis Risk in Communities (ARIC) study, baseline sRAGE levels were measured in a cohort random sample of participants without kidney disease (n = 1218), and among participants who developed incident chronic kidney disease (CKD) [estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) and >= 25% eGFR decline, n = 151] and end-stage renal disease (ESRD) [entry in the US Renal Data System (USRDS) registry, n = 152]. Results. Baseline sRAGE levels were inversely related to baseline eGFR (r = -0.13). After adjusting for age, sex and race, one interquartile range higher log(10)-transformed sRAGE was associated with development of CKD [odds ratio: 1.39; 95% confidence interval (95% CI) 1.06-1.83; P = 0.02] and ESRD (hazard ratio: 1.97; 95% CI 1.47-2.64; P < 0.001). These associations were not significant after eGFR adjustment. Conclusions. High sRAGE levels are associated with incident CKD and ESRD risk, but not after adjustment for kidney function at baseline. Future studies are needed to investigate specific mechanisms underlying the association of sRAGE with kidney disease risk.

Metrics

14 Record Views
37 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Transplantation
Urology & Nephrology
Logo image